74 related articles for article (PubMed ID: 1737335)
1. A new form of cytochrome P-450 responsible for mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline in human livers.
Ubukata K; Ohi H; Kitada M; Kamataki T
Cancer Res; 1992 Feb; 52(4):758-63. PubMed ID: 1737335
[TBL] [Abstract][Full Text] [Related]
2. Metabolic activation of aflatoxin B1 and 2-amino-3-methylimidazo[4,5-f]-quinoline by human adult and fetal livers.
Kitada M; Taneda M; Ohta K; Nagashima K; Itahashi K; Kamataki T
Cancer Res; 1990 May; 50(9):2641-5. PubMed ID: 2109655
[TBL] [Abstract][Full Text] [Related]
3. Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
Sadrieh N; Snyderwine EG
Carcinogenesis; 1995 Jul; 16(7):1549-55. PubMed ID: 7614688
[TBL] [Abstract][Full Text] [Related]
4. Mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline by complementary DNA-expressed human liver P-450.
Aoyama T; Gelboin HV; Gonzalez FJ
Cancer Res; 1990 Apr; 50(7):2060-3. PubMed ID: 2180561
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450.
McManus ME; Burgess WM; Veronese ME; Huggett A; Quattrochi LC; Tukey RH
Cancer Res; 1990 Jun; 50(11):3367-76. PubMed ID: 2334931
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of environmental carcinogens and mutagens by human liver microsomes. Role of cytochrome P-450 homologous to a 3-methylcholanthrene-inducible isozyme in rat liver.
Shimada T; Okuda Y
Biochem Pharmacol; 1988 Feb; 37(3):459-65. PubMed ID: 3337745
[TBL] [Abstract][Full Text] [Related]
7. Specificity of rabbit cytochrome P-450 isozymes involved in the metabolic activation of the food derived mutagen 2-amino-3-methylimidazo[4,5-f] quinoline.
McManus ME; Burgess W; Snyderwine E; Stupans I
Cancer Res; 1988 Aug; 48(16):4513-9. PubMed ID: 3396004
[TBL] [Abstract][Full Text] [Related]
8. Four forms of cytochrome P-450 in human fetal liver: purification and their capacity to activate promutagens.
Kitada M; Taneda M; Itahashi K; Kamataki T
Jpn J Cancer Res; 1991 Apr; 82(4):426-32. PubMed ID: 1904422
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of anthraquinones as inhibitors of 7-ethoxycoumarin O-deethylase and mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline.
Hao NJ; Huang MP; Lee H
Mutat Res; 1995 May; 328(2):183-91. PubMed ID: 7739602
[TBL] [Abstract][Full Text] [Related]
10. Mutagenic activation of aflatoxin B1 by P-450 HFLa in human fetal livers.
Kitada M; Taneda M; Ohi H; Komori M; Itahashi K; Nagao M; Kamataki T
Mutat Res; 1989 Sep; 227(1):53-8. PubMed ID: 2549412
[TBL] [Abstract][Full Text] [Related]
11. Microsomal activation of 2-amino-3-methylimidazo[4,5-f]quinoline, a pyrolysate of sardine and beef extracts, to a mutagenic intermediate.
Yamazoe Y; Shimada M; Kamataki T; Kato R
Cancer Res; 1983 Dec; 43(12 Pt 1):5768-74. PubMed ID: 6416669
[TBL] [Abstract][Full Text] [Related]
12. Ascorbic acid deficiency decreases specific forms of cytochrome P-450 in liver microsomes of guinea pigs.
Kanazawa Y; Kitada M; Mori T; Inukai Y; Imaoka S; Funae Y; Kamataki T
Mol Pharmacol; 1991 Apr; 39(4):456-60. PubMed ID: 1901938
[TBL] [Abstract][Full Text] [Related]
13. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002.
Shimada T; Iwasaki M; Martin MV; Guengerich FP
Cancer Res; 1989 Jun; 49(12):3218-28. PubMed ID: 2655891
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical characterization and toxicological significance of P-450HFLb purified from human fetal livers.
Kitada M; Kato T; Ohmori S; Kamataki T; Itahashi K; Guengerich FP; Rikihisa T; Kanakubo Y
Biochim Biophys Acta; 1992 Oct; 1117(3):301-5. PubMed ID: 1420280
[TBL] [Abstract][Full Text] [Related]
15. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.
Butler MA; Iwasaki M; Guengerich FP; Kadlubar FF
Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7696-700. PubMed ID: 2813353
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of dietary 4-ipomeanol on DNA adduct formation by the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in male CDF1 mice.
Cummings DA; Schut HA
Carcinogenesis; 1995 Oct; 16(10):2523-9. PubMed ID: 7586161
[TBL] [Abstract][Full Text] [Related]
17. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes.
Kamataki T; Maeda K; Yamazoe Y; Matsuda N; Ishii K; Kato R
Mol Pharmacol; 1983 Jul; 24(1):146-55. PubMed ID: 6408394
[TBL] [Abstract][Full Text] [Related]
18. Hepatocarcinogenic heterocyclic aromatic amines that induce cytochrome P-448 isozymes, mainly cytochrome P-448H (P-450IA2), responsible for mutagenic activation of the carcinogens in rat liver.
Degawa M; Tanimura S; Agatsuma T; Hashimoto Y
Carcinogenesis; 1989 Jun; 10(6):1119-22. PubMed ID: 2720904
[TBL] [Abstract][Full Text] [Related]
19. Specificity of four forms of cytochrome P-450 in the metabolic activation of several aromatic amines and benzo[a]pyrene.
Yamazoe Y; Shimada M; Maeda K; Kamataki T; Kato R
Xenobiotica; 1984 Jul; 14(7):549-52. PubMed ID: 6438922
[TBL] [Abstract][Full Text] [Related]
20. The structure-activity relationships of flavonoids as inhibitors of cytochrome P-450 enzymes in rat liver microsomes and the mutagenicity of 2-amino-3-methyl-imidazo[4,5-f]quinoline.
Lee H; Wang HW; Su HY; Hao NJ
Mutagenesis; 1994 Mar; 9(2):101-6. PubMed ID: 8201941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
